Table 2.

Treatment delivery

n (%)
Number of cycles
 <15 (12.5)
 17 (17.5)
 218 (45)
 3–46 (15)
 5–61 (2.5)
 >63 (7.5)
Reason for discontinuation
 Disease progression35 (87.5)
 Adverse event3 (7.5)
 Protocol violation1 (2.5)
 Lost to follow-up1 (2.5)